LZTS2, leucine zipper tumor suppressor 2, 84445

N. diseases: 22; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.080 PosttranslationalModification group BEFREE The qMSP analyses revealed that LZTS2 promoter methylation levels in the LSCC tumor samples were significantly higher than those in paired adjacent healthy tissue samples. 29499699 2018
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.080 Biomarker group BEFREE The leucine zipper tumor suppressor 2 (LZTS2) was identified as a tumor susceptibility gene within the 10q24.3 chromosomal region, and is approximately 15Mb from the PTEN locus. 28323888 2017
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.080 Biomarker group BEFREE In conclusion, our results demonstrate the critical role of miR-300 in GSLCs and its functions in LZTS2 inhibition and describe a new approach for the molecular regulation of tumor stem cells. 24464870 2014
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.080 GeneticVariation group BEFREE These data provide the first line of evidence demonstrating that deletion of Lzts2 increases susceptibility to spontaneous and carcinogen-induced tumor development. 23275340 2013
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.080 AlteredExpression group BEFREE We found that low levels of LZTS2 in NSCLC were correlated with tumor and nodal status. 23761130 2013
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.080 Biomarker group BEFREE LAPSER1 has been identified as a candidate tumor suppressor gene in prostate cancer, but its true functions remain unknown. 17351128 2007
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.080 PosttranslationalModification group BEFREE The LZTS2 gene is located at 10q24.3, which is frequently lost in a variety of human tumors. 17000760 2006
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.080 Biomarker group BEFREE LAPSER1: a novel candidate tumor suppressor gene from 10q24.3. 11709705 2001